For our Annual Review 2019: Towards a decade of action, we spoke to Gregory Rockson, Chief Executive Officer of mPharma.
Related posts
-
Collaborating to accelerate investment in climate adaptation and resilience
-
We’ve published our Annual Review 2020: Rising to the challenge
-
British International Investment announces 2022 annual results with £1.27 billion of new impact investments
-
Annual Review 2019: iMerit Founder and Chief Executive Officer, Radha Basu
-
Annual Review 2019: CEO of Zephyr Power, Kumayl Khaleeli
-
CDC pledges to deliver a decade of impact investing in support of the UN’s Sustainable Development Goals
-
CDC Group announces co-investment in mPharma under Venture Scale-Up Programme
-
Making a difference: read our 2018 Annual Review and Annual Accounts
-
Forward with purpose: Read our Annual Review and Accounts
-
Annual Review 2016 – Interview with the CEO and Chairman
-
Read our Annual Review 2016, ‘Supporting the potential of people’
-
Annual Review 2015 shows CDC growing in ambition and impact